Skip to Content

669 Results Found

  • Communication
  • Open Access
3 Citations
6,373 Views
9 Pages

Stem Cell Replacement Improves Expression of SMP30 in db/db Mice

  • Ming Li,
  • Kequan Guo,
  • Shigeru Taketani,
  • Yasushi Adachi and
  • Susumu Ikehara

16 December 2015

We have previously reported that replacing bone marrow stem cells may improve hyperglycemia and oxidative stress in db/db mice, a type 2 diabetic mouse model. Senescence marker protein 30 (SMP30) is an antioxidant protein that decreases with aging. H...

(This article belongs to the Special Issue Stem Cell Activation in Adult Organism)
  • Review
  • Open Access
14 Citations
8,797 Views
19 Pages

22 February 2023

Cell replacement therapy using stem-cell-derived insulin-producing β-like cells (sBCs) has been proposed as a practical cure for patients with type one diabetes (T1D). sBCs can correct diabetes in preclinical animal models, demonstrating the pro...

(This article belongs to the Section Stem Cells)
  • Review
  • Open Access
1 Citations
3,045 Views
22 Pages

Engineering Stem Cells for Islet Replacement Therapy: Recent Advances and Barriers for Clinical Translation

  • Jayachandra Kuncha,
  • Sharmila Devi Veeraswamy,
  • Carly M. Darden,
  • Jeffrey Kirkland and ,
  • Michael C. Lawrence,
  • Juan S. Danobeitia and
  • Bashoo Naziruddin
  • + 2 authors+ 0 author

17 March 2026

Diabetes mellitus remains a leading cause of morbidity worldwide, driven in type 1 diabetes by autoimmune destruction of pancreatic β-cells and in advanced type 2 diabetes by progressive β-cell dysfunction and failure. Diabetes affects arou...

(This article belongs to the Special Issue Advances and Breakthroughs in Stem Cell Research)
  • Review
  • Open Access
21 Citations
7,900 Views
30 Pages

Cell Therapy for Retinal Degenerative Diseases: Progress and Prospects

  • Kevin Y. Wu,
  • Jaskarn K. Dhaliwal,
  • Akash Sasitharan and
  • Ananda Kalevar

Background/Objectives: Age-related macular degeneration (AMD) and retinitis pigmentosa (RP) are leading causes of vision loss, with AMD affecting older populations and RP being a rarer, genetically inherited condition. Both diseases result in progres...

(This article belongs to the Special Issue Where Are We Now and Where Is Cell Therapy Headed?)
  • Review
  • Open Access
19 Citations
5,383 Views
14 Pages

Where Are We with RPE Replacement Therapy? A Translational Review from the Ophthalmologist Perspective

  • Raffaele Raimondi,
  • Piero Zollet,
  • Francesco Paolo De Rosa,
  • Panagiotis Tsoutsanis and ,
  • Matteo Stravalaci,
  • Marianna Paulis,
  • Antonio Inforzato and
  • Mario R. Romano
  • + 3 authors+ 0 author

The retinal pigmented epithelium (RPE) plays a pivotal role in retinal homeostasis. It is therefore an interesting target to fill the unmet medical need of different retinal diseases, including age-related macular degeneration and Stargardt disease....

(This article belongs to the Special Issue Novel Insights in Retinal Diseases Pathophysiology and Therapies)
  • Review
  • Open Access
32 Citations
6,553 Views
13 Pages

Glaucoma is a group of irreversible blinding eye diseases characterized by the progressive loss of retinal ganglion cells (RGCs) and their axons. Currently, there is no effective method to fundamentally resolve the issue of RGC degeneration. Recent a...

(This article belongs to the Special Issue Cellular Therapies for Glaucoma)
  • Review
  • Open Access
37 Citations
8,429 Views
25 Pages

The aim of this review was to provide an update on the potential of cell therapies to restore or replace damaged and/or lost cells in retinal degenerative and optic nerve diseases, describing the available cell sources and the challenges involved in...

(This article belongs to the Special Issue Advanced Therapy Medicinal Products for Eye Diseases: Goals and Challenges)
  • Review
  • Open Access
1,561 Views
27 Pages

Stem Cell Therapy for Parkinson’s Disease: A Mechanistically Distinct Role for Muse Cells

  • Michael H. Mesches,
  • Ann-Charlotte Granholm,
  • Daniel Paredes,
  • Karin Mesches and ,
  • Yo Oguma and
  • Mari Dezawa
  • + 1 author+ 0 author

5 June 2026

Cell replacement therapy is a promising investigational approach for Parkinson’s disease (PD), a neurodegenerative disorder characterized by progressive loss of dopaminergic neurons in the substantia nigra. Although current PD therapies provide...

(This article belongs to the Section Brain Injury)
  • Review
  • Open Access
409 Citations
30,325 Views
16 Pages

30 April 2019

Induced pluripotent stem cell (iPSC)-based disease modelling and the cell replacement therapy approach have proven to be very powerful and instrumental in biomedical research and personalized regenerative medicine as evidenced in the past decade by u...

(This article belongs to the Special Issue iPS Cells for Disease Modeling)
  • Article
  • Open Access
8 Citations
4,000 Views
17 Pages

Ex Vivo Integration of Human Stem Retinal Ganglion Cells into the Mouse Retina

  • Louis-Philippe Croteau,
  • Michael L. Risner,
  • Lauren K. Wareham,
  • Nolan R. McGrady and ,
  • Xitiz Chamling,
  • Donald J. Zack and
  • David J. Calkins
  • + 2 authors+ 0 author

15 October 2022

Cell replacement therapies may be key in achieving functional recovery in neurodegenerative optic neuropathies diseases such as glaucoma. One strategy that holds promise in this regard is the use of human embryonic stem cell and induced pluripotent s...

(This article belongs to the Section Stem Cells)
  • Case Report
  • Open Access
15 Citations
6,093 Views
13 Pages

First Report of a Patient with MPS Type VII, Due to Novel Mutations in GUSB, Who Underwent Enzyme Replacement and Then Hematopoietic Stem Cell Transplantation

  • Patricia Dubot,
  • Frédérique Sabourdy,
  • Geneviève Plat,
  • Charlotte Jubert and ,
  • Claude Cancès,
  • Pierre Broué,
  • Guy Touati and
  • Thierry Levade
  • + 3 authors+ 0 author

28 October 2019

We report the case of a boy who was diagnosed with mucopolysaccharidosis (MPS) VII at two weeks of age. He harbored three missense β-glucuronidase (GUSB) variations in exon 3: two novel, c.422A>C and c.424C>T, inherited from his mother, an...

(This article belongs to the Special Issue Mucopolysaccharidoses: Diagnosis, Treatment, and Management)
  • Review
  • Open Access
26 Citations
10,400 Views
16 Pages

Stem Cells as Potential Candidates for Psoriasis Cell-Replacement Therapy

  • Agnieszka Owczarczyk-Saczonek,
  • Magdalena Krajewska-Włodarczyk,
  • Anna Kruszewska,
  • Waldemar Placek and ,
  • Wojciech Maksymowicz and
  • Joanna Wojtkiewicz
  • + 1 author+ 0 author

20 October 2017

Recent years have seen considerable progress in explaining the mechanisms of the pathogenesis of psoriasis, with a significant role played in it by the hyper-reactivity of Th1 and Th17 cells, Treg function disorder, as well as complex relationships b...

(This article belongs to the Special Issue Psoriasis)
  • Article
  • Open Access
13 Citations
8,650 Views
23 Pages

Human-Induced Pluripotent Stem Cell-Derived Neural Progenitor Cells Showed Neuronal Differentiation, Neurite Extension, and Formation of Synaptic Structures in Rodent Ischemic Stroke Brains

  • Yonehiro Kanemura,
  • Atsuyo Yamamoto,
  • Asako Katsuma,
  • Hayato Fukusumi and ,
  • Tomoko Shofuda,
  • Daisuke Kanematsu,
  • Yukako Handa,
  • Miho Sumida,
  • Ema Yoshioka and
  • Hideyuki Okano
  • + 12 authors+ 7 authors

12 April 2024

Ischemic stroke is a major cerebrovascular disease with high morbidity and mortality rates; however, effective treatments for ischemic stroke-related neurological dysfunction have yet to be developed. In this study, we generated neural progenitor cel...

(This article belongs to the Collection Stem Cell-Based Therapy, Disease Modeling and Drug Discovery)
  • Review
  • Open Access
1 Citations
1,121 Views
31 Pages

Advances in Therapies for Mucopolysaccharidoses

  • Joanna Szmydtka,
  • Maja Ziemian,
  • Rafał Banaszak,
  • Martyna Ciesielska and ,
  • Jagoda Ładosz,
  • Urszula Maliszewska,
  • Adrian Nowakowski,
  • Martyna Paszek,
  • Gabriela Suproń and
  • Grzegorz Węgrzyn
  • + 8 authors+ 3 authors

Mucopolysaccharidoses (MPS) are severe, inherited metabolic diseases, classified among lysosomal storage diseases (LSDs). The presence of pathological variants of genes coding for enzymes involved in the degradation of glycosaminoglycans (GAGs) is a...

(This article belongs to the Special Issue Complex Molecular Mechanism of Monogenic Diseases: 3rd Edition)
  • Review
  • Open Access
77 Citations
24,390 Views
23 Pages

Mucopolysaccharidosis Type I

  • Francyne Kubaski,
  • Fabiano de Oliveira Poswar,
  • Kristiane Michelin-Tirelli,
  • Ursula da Silveira Matte and ,
  • Dafne D. Horovitz,
  • Anneliese Lopes Barth,
  • Guilherme Baldo,
  • Filippo Vairo and
  • Roberto Giugliani
  • + 4 authors+ 0 author

Mucopolysaccharidosis type I (MPS I) is caused by the deficiency of α-l-iduronidase, leading to the storage of dermatan and heparan sulfate. There is a broad phenotypical spectrum with the presence or absence of neurological impairment. The cla...

(This article belongs to the Special Issue Mucopolysaccharidoses: Diagnosis, Treatment, and Management)
  • Review
  • Open Access
87 Citations
14,744 Views
24 Pages

Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement

  • Christiane S. Hampe,
  • Jacob Wesley,
  • Troy C. Lund,
  • Paul J. Orchard and ,
  • Lynda E. Polgreen,
  • Julie B. Eisengart,
  • Linda K. McLoon,
  • Sebahattin Cureoglu,
  • Patricia Schachern and
  • R. Scott McIvor
  • + 5 authors+ 0 author

29 January 2021

Mucopolysaccharidosis type I (MPS I) is a lysosomal disease, caused by a deficiency of the enzyme alpha-L-iduronidase (IDUA). IDUA catalyzes the degradation of the glycosaminoglycans dermatan and heparan sulfate (DS and HS, respectively). Lack of the...

(This article belongs to the Special Issue Lysosomal Storage Disorders: Molecular Basis and Therapeutic Approaches)
  • Case Report
  • Open Access
5 Citations
3,202 Views
8 Pages

Early Neonatal Cardiac Phenotype in Hurler Syndrome: Case Report and Literature Review

  • Nishitha R. Pillai,
  • Alia Ahmed,
  • Todd Vanyo and
  • Chester B. Whitley

22 July 2022

Mucopolysaccharidosis type I (MPS I) is a rare inherited lysosomal disorder caused by deficiency of the α-L-iduronidase enzyme, resulting in the progressive accumulation of glycosaminoglycans (GAGs), which interfere with the normal function of...

(This article belongs to the Section Human Genomics and Genetic Diseases)
  • Review
  • Open Access
617 Views
12 Pages

Genetically modified hematopoietic stem cell therapy using gene-modified autologous hematopoietic stem cells has evolved over the last 30 years as an alternative approach to circumvent the limitations of donor availability, risks of excessive regimen...

(This article belongs to the Section Molecular Biology)
  • Review
  • Open Access
1 Citations
4,334 Views
38 Pages

The Evolving Landscape of Fetal Therapy: Surgical Interventions and Emerging Biologics

  • Berna Seker-Yilmaz,
  • Melissa Hill,
  • Giovanni Baranello,
  • Stavros Loukogeorgakis and ,
  • Paolo De Coppi,
  • Paul Gissen and
  • Lyn S. Chitty
  • + 2 authors+ 0 author

Fetal therapy has evolved into a rapidly advancing field with the potential to alter the natural history of many severe congenital and genetic disorders before irreversible injury occurs. Progress in prenatal imaging, molecular diagnostics, and fetal...

(This article belongs to the Special Issue Gene and Stem Cell Therapies for Inherited Metabolic Disorders)
  • Article
  • Open Access
19 Citations
5,342 Views
22 Pages

Newborn Screening Program for Mucopolysaccharidosis Type II and Long-Term Follow-Up of the Screen-Positive Subjects in Taiwan

  • Hsiang-Yu Lin,
  • Ya-Hui Chang,
  • Chung-Lin Lee,
  • Yuan-Rong Tu and ,
  • Yun-Ting Lo,
  • Pei-Wen Hung,
  • Dau-Ming Niu,
  • Mei-Ying Liu,
  • Hsin-Yun Liu and
  • Shuan-Pei Lin
  • + 10 authors+ 5 authors

21 June 2022

Background: Mucopolysaccharidosis II (MPS II) is an X-linked disorder resulting from a deficiency in lysosomal enzyme iduronate-2-sulfatase (IDS), which causes the accumulation of glycosaminoglycans (GAGs) in the lysosomes of many tissues and organs,...

(This article belongs to the Section Methodology, Drug and Device Discovery)
  • Review
  • Open Access
7 Citations
6,784 Views
32 Pages

Botanicals and Oral Stem Cell Mediated Regeneration: A Paradigm Shift from Artificial to Biological Replacement

  • Anami Ahuja,
  • Pankaj Kumar Tyagi,
  • Manoj Kumar,
  • Naveen Sharma and ,
  • Suraj Prakash,
  • Radha,
  • Deepak Chandran,
  • Sangram Dhumal,
  • Nadeem Rais and
  • Mohamed Mekhemar
  • + 18 authors+ 13 authors

7 September 2022

Stem cells are a well-known autologous pluripotent cell source, having excellent potential to develop into specialized cells, such as brain, skin, and bone marrow cells. The oral cavity is reported to be a rich source of multiple types of oral stem c...

(This article belongs to the Special Issue Microenvironmental Factors and Functional Modulation in Mesenchymal Stem Cells)
  • Article
  • Open Access
2 Citations
4,827 Views
14 Pages

DJ-1 Can Replace FGF-2 for Long-Term Culture of Human Pluripotent Stem Cells in Defined Media and Feeder-Free Condition

  • Julee Kim,
  • Sangki Baek,
  • Yean Ju Hong,
  • Michelle Novais de Paula and ,
  • Musharrat Jahan Prima,
  • Yeon-Mok Oh,
  • Sun-Shin Cha,
  • Jeong Tae Do,
  • Yeon Jin Jang and
  • Han Choe
  • + 5 authors+ 0 author

Conventional human pluripotent stem cell (hPSC) cultures require high concentrations of expensive human fibroblast growth factor 2 (hFGF-2) for hPSC self-renewal and pluripotency in defined media for long-term culture. The thermal instability of the...

(This article belongs to the Special Issue Pluripotent Stem Cells 2021)
  • Review
  • Open Access
7 Citations
4,573 Views
17 Pages

10 November 2021

Personalized regenerative medicine and biomedical research have been galvanized and revolutionized by human pluripotent stem cells in combination with recent advances in genomics, artificial intelligence, and genome engineering. More recently, we hav...

(This article belongs to the Section Stem Cells)
  • Article
  • Open Access
23 Citations
6,773 Views
27 Pages

Growth Factors VEGF-A165 and FGF-2 as Multifunctional Biomolecules Governing Cell Adhesion and Proliferation

  • Antonín Sedlář,
  • Martina Trávníčková,
  • Roman Matějka,
  • Šimon Pražák and ,
  • Zuzana Mészáros,
  • Pavla Bojarová,
  • Lucie Bačáková,
  • Vladimír Křen and
  • Kristýna Slámová
  • + 4 authors+ 0 author

12 February 2021

Vascular endothelial growth factor-A165 (VEGF-A165) and fibroblast growth factor-2 (FGF-2) are currently used for the functionalization of biomaterials designed for tissue engineering. We have developed a new simple method for heterologous expression...

(This article belongs to the Special Issue 25th Anniversary of IJMS: Advances in Biochemistry)
  • Review
  • Open Access
52 Citations
9,581 Views
29 Pages

8 June 2021

As part of the central nervous system, mammalian retinal ganglion cells (RGCs) lack significant regenerative capacity. Glaucoma causes progressive and irreversible vision loss by damaging RGCs and their axons, which compose the optic nerve. To functi...

(This article belongs to the Special Issue Retinal Ganglion Cell Neuroprotection: Approaches to the Treatment of Optic Neuropathies)
  • Article
  • Open Access
8 Citations
4,352 Views
21 Pages

Human iPSC-Derived Renal Cells Change Their Immunogenic Properties during Maturation: Implications for Regenerative Therapies

  • Bella Rossbach,
  • Krithika Hariharan,
  • Nancy Mah,
  • Su-Jun Oh and ,
  • Hans-Dieter Volk,
  • Petra Reinke and
  • Andreas Kurtz
  • + 2 authors+ 0 author

13 April 2022

The success of human induced pluripotent stem cell (hiPSC)-based therapy critically depends on understanding and controlling the immunological effects of the hiPSC-derived transplant. While hiPSC-derived cells used for cell therapy are often immature...

(This article belongs to the Section Stem Cells)
  • Article
  • Open Access
23 Citations
4,630 Views
25 Pages

The Impact of Biomaterial Surface Properties on Engineering Neural Tissue for Spinal Cord Regeneration

  • Victor A. da Silva,
  • Bianca C. Bobotis,
  • Felipe F. Correia,
  • Théo H. Lima-Vasconcellos and ,
  • Gabrielly M. D. Chiarantin,
  • Laura De La Vega,
  • Christiane B. Lombello,
  • Stephanie M. Willerth,
  • Sônia M. Malmonge and
  • Alexandre H. Kihara
  • + 6 authors+ 1 author

4 September 2023

Tissue engineering for spinal cord injury (SCI) remains a complex and challenging task. Biomaterial scaffolds have been suggested as a potential solution for supporting cell survival and differentiation at the injury site. However, different biomater...

(This article belongs to the Special Issue Medical Polymers for Tissue Repair and Regeneration)
  • Article
  • Open Access
12 Citations
3,948 Views
19 Pages

We studied cell proliferation in the postnatal mouse brain between the ages of 2 and 30 months and identified four compartments with different densities of proliferating cells. The first identified compartment corresponds to the postnatal pallial neu...

(This article belongs to the Special Issue Neuron and Brain Maturation)
  • Article
  • Open Access
7 Citations
2,510 Views
16 Pages

In Vitro Characterization of Human Cell Sources in Collagen Type I Gel Scaffold for Meniscus Tissue Engineering

  • Barbara Canciani,
  • Nicolò Rossi,
  • Elena Arrigoni,
  • Riccardo Giorgino and ,
  • Mirko Sergio,
  • Lucia Aidos,
  • Mauro Di Giancamillo,
  • Valentina Rafaela Herrera Millar,
  • Giuseppe M. Peretti and
  • Laura Mangiavini
  • + 6 authors+ 1 author

25 November 2024

Strategies to repair the meniscus have achieved limited success; thus, a cell-based therapy combined with an appropriate biocompatible scaffold could be an interesting alternative to overcome this issue. The aim of this project is to analyze differen...

(This article belongs to the Special Issue Recent Research on Medical Hydrogels)
  • Review
  • Open Access
46 Citations
15,101 Views
26 Pages

Gene Therapy Developments for Pompe Disease

  • Zeenath Unnisa,
  • John K. Yoon,
  • Jeffrey W. Schindler,
  • Chris Mason and
  • Niek P. van Til

Pompe disease is an inherited neuromuscular disorder caused by deficiency of the lysosomal enzyme acid alpha-glucosidase (GAA). The most severe form is infantile-onset Pompe disease, presenting shortly after birth with symptoms of cardiomyopathy, res...

(This article belongs to the Special Issue New Insights in Gene and Cell Therapy)
  • Review
  • Open Access
67 Citations
9,854 Views
12 Pages

Newborn screening for lysosomal storage diseases (LSDs) is increasingly being considered as an option. The development of analytical screening methods, of second-tier methods, and of therapeutic possibilities, are paving the way for routine screening...

  • Review
  • Open Access
60 Citations
7,198 Views
16 Pages

Three-Dimensional Bioprinting Applications for Bone Tissue Engineering

  • Jamie A. Maresca,
  • Derek C. DeMel,
  • Grayson A. Wagner,
  • Colin Haase and
  • John P. Geibel

24 April 2023

The skeletal system is a key support structure within the body. Bones have unique abilities to grow and regenerate after injury. Some injuries or degeneration of the tissues cannot rebound and must be repaired by the implantation of foreign objects f...

  • Review
  • Open Access
36 Citations
13,111 Views
15 Pages

Acute Kidney Injury in the Patient with Cancer

  • Alejandro Meraz-Munoz,
  • Amit Langote,
  • Kenar D. Jhaveri,
  • Hassane Izzedine and
  • Prakash Gudsoorkar

Over the last three decades, advancements in the diagnosis, treatment, and supportive care of patients with cancer have significantly improved their overall survival. However, these advancements have also led to a higher rate of cancer-related compli...

(This article belongs to the Special Issue Research Progress in NephroOncology)
  • Review
  • Open Access
10 Citations
4,848 Views
28 Pages

Mucopolysaccharidoses—What Clinicians Need to Know: A Clinical, Biochemical, and Molecular Overview

  • Patryk Lipiński,
  • Agnieszka Różdżyńska-Świątkowska,
  • Karolina Wiśniewska,
  • Joanna Rusecka and ,
  • Agnieszka Ługowska,
  • Zbigniew Żuber,
  • Aleksandra Jezela-Stanek,
  • Zuzanna Cyske,
  • Lidia Gaffke and
  • Anna Tylki-Szymańska
  • + 7 authors+ 2 authors

14 October 2025

The classification of mucopolysaccharidoses (MPSs) includes the classical types (I; II; III with subtypes A, B, C, and D; IV with subtypes A and B; VI; VII; IX; X), associated with impaired lysosomal degradation of mucopolysaccharides, also known as...

(This article belongs to the Special Issue Updates on Molecular Mechanisms of Lysosomal Storage Disease)
  • Review
  • Open Access
1 Citations
1,072 Views
16 Pages

9 July 2026

Background: A widely cited 2024 analysis reported that only 5% of therapeutic interventions tested in animals obtain regulatory approval for human use, reviving the debate about the predictive value of animal models. This review asks how the scientif...

  • Review
  • Open Access
1 Citations
275 Views
6 Pages

Cardiovascular In Situ Tissue Engineering

  • Benedikt Weber,
  • Volkmar Falk and
  • Simon P. Hoerstrup

19 December 2012

Structural cardiovascular disease is responsible for a significant disease load worldwide. Although currently used replacement procedures are efficacious and change the deadly evolution of many structural cardiovascular defects, the clinically used r...

  • Review
  • Open Access
17 Citations
6,468 Views
17 Pages

Proposed Mechanisms of Cell Therapy for Alzheimer’s Disease

  • Ekaterina Belousova,
  • Diana Salikhova,
  • Yaroslav Maksimov,
  • Vladimir Nebogatikov and ,
  • Anastasiya Sudina,
  • Dmitry Goldshtein and
  • Aleksey Ustyugov
  • + 2 authors+ 0 author

18 November 2024

Alzheimer’s disease is a progressive neurodegenerative disorder characterized by mitochondria dysfunction, accumulation of beta-amyloid plaques, and hyperphosphorylated tau tangles in the brain leading to memory loss and cognitive deficits. The...

(This article belongs to the Special Issue From Molecular Insights to Novel Therapies: Neurological Diseases)
  • Review
  • Open Access
44 Citations
12,209 Views
20 Pages

Stem Cells: Innovative Therapeutic Options for Neurodegenerative Diseases?

  • Gabriele Bonaventura,
  • Antonio Munafò,
  • Carlo Maria Bellanca,
  • Valentina La Cognata and ,
  • Rosario Iemmolo,
  • Giuseppe Antonino Attaguile,
  • Rosaria Di Mauro,
  • Giulia Di Benedetto,
  • Giuseppina Cantarella and
  • Renato Bernardini
  • + 7 authors+ 2 authors

5 August 2021

Neurodegenerative diseases are characterized by the progressive loss of structure and/or function of both neurons and glial cells, leading to different degrees of pathology and loss of cognition. The hypothesis of circuit reconstruction in the damage...

(This article belongs to the Special Issue Mechanisms of Neurodevelopment and Neurodegeneration)
  • Review
  • Open Access
12 Citations
7,107 Views
22 Pages

Stem Cell Therapy for Acute/Subacute Ischemic Stroke with a Focus on Intraarterial Stem Cell Transplantation: From Basic Research to Clinical Trials

  • Susumu Yamaguchi,
  • Michiharu Yoshida,
  • Nobutaka Horie,
  • Katsuya Satoh and ,
  • Yuutaka Fukuda,
  • Shunsuke Ishizaka,
  • Koki Ogawa,
  • Yoichi Morofuji,
  • Takeshi Hiu and
  • Takayuki Matsuo
  • + 8 authors+ 3 authors

Stem cell therapy for ischemic stroke holds great promise for the treatment of neurological impairment and has moved from the laboratory into early clinical trials. The mechanism of action of stem cell therapy includes the bystander effect and cell r...

  • Review
  • Open Access
3 Citations
2,921 Views
16 Pages

29 February 2024

Numerous reports have demonstrated the breakdown of the blood–CNS barrier (B-CNS-B) in amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disease. Re-establishing barrier integrity in the CNS is critical to prevent further motor neu...

(This article belongs to the Section Cells of the Cardiovascular System)
  • Review
  • Open Access
16 Citations
9,006 Views
23 Pages

18 October 2012

Retinal degenerative diseases constitute a major cause of irreversible blindness in the world. Stem cell-based therapies offer hope for these patients at risk of or suffering from blindness due to the deterioration of the neural retina. Various sourc...

(This article belongs to the Special Issue Tissue and Organ Regeneration)
  • Review
  • Open Access
30 Citations
10,401 Views
15 Pages

8 December 2016

The field of stem cell biology has rapidly evolved in the last few decades. In the area of regenerative medicine, clinical applications using stem cells hold the potential to be a powerful tool in the treatment of a wide variety of diseases, in parti...

(This article belongs to the Special Issue Ten Years of iPSCs: Current Status and Future Perspectives)
  • Review
  • Open Access
32 Citations
6,662 Views
24 Pages

Therapeutic Functions of Stem Cells from Oral Cavity: An Update

  • Ji Won Yang,
  • Ye Young Shin,
  • Yoojin Seo and
  • Hyung-Sik Kim

Adult stem cells have been developed as therapeutics for tissue regeneration and immune regulation due to their self-renewing, differentiating, and paracrine functions. Recently, a variety of adult stem cells from the oral cavity have been discovered...

(This article belongs to the Special Issue Novel MSC Perspectives: From Cell Regulation to Tissue Regeneration 2.0)
  • Review
  • Open Access
17 Citations
11,263 Views
13 Pages

24 December 2020

This review provides an up-to-date source of information on the primary auditory neurons or spiral ganglion neurons in the cochlea. These neurons transmit auditory information in the form of electric signals from sensory hair cells to the first audit...

(This article belongs to the Special Issue Neurons of the Auditory Pathways)
  • Review
  • Open Access
16 Citations
12,089 Views
16 Pages

Stem Cells for the Treatment of Neurodegenerative Diseases

  • Yong-Ping Wu,
  • Wei-Shan Chen,
  • Chong Teng and
  • Ning Zhang

27 September 2010

Neurodegenerative diseases are characterized by neurodegenerative changes or apoptosis of neurons involved in networks, leading to permanent paralysis and loss of sensation below the site of the injury. Cell replacement therapy has provided the basis...

  • Review
  • Open Access
14 Citations
10,641 Views
18 Pages

24 March 2014

Transplantation of stem cells for the treatment of Huntington’s disease (HD) garnered much attention prior to the turn of the century. Several studies using mesenchymal stem cells (MSCs) have indicated that these cells have enormous therapeutic poten...

  • Review
  • Open Access
4 Citations
8,553 Views
10 Pages

15 September 2010

The use of neuroprotective therapies begs the question of how such therapies could affect preexisting stem cell populations within the host, as well as those introduced through cell-replacement therapy. Multiple mechanisms may mediate stem cell respo...

  • Review
  • Open Access
17 Citations
5,712 Views
43 Pages

Perinatal Tissue-Derived Stem Cells: An Emerging Therapeutic Strategy for Challenging Neurodegenerative Diseases

  • Annalisa Bruno,
  • Cristina Milillo,
  • Federico Anaclerio,
  • Carlotta Buccolini and ,
  • Anastasia Dell’Elice,
  • Ilaria Angilletta,
  • Marco Gatta,
  • Patrizia Ballerini and
  • Ivana Antonucci
  • + 4 authors+ 0 author

Over the past 20 years, stem cell therapy has been considered a promising option for treating numerous disorders, in particular, neurodegenerative disorders. Stem cells exert neuroprotective and neurodegenerative benefits through different mechanisms...

(This article belongs to the Special Issue Stem Cells in Health and Disease 2.0)
  • Review
  • Open Access
4 Citations
9,385 Views
17 Pages

Epidermal Stem Cells in Orthopaedic Regenerative Medicine

  • Jin Li,
  • Gehua Zhen,
  • Shin-Yi Tsai and
  • Xiaofeng Jia

31 May 2013

In the last decade, great advances have been made in epidermal stem cell studies at the cellular and molecular level. These studies reported various subpopulations and differentiations existing in the epidermal stem cell. Although controversies and...

(This article belongs to the Special Issue Molecular Research of Epidermal Stem Cells)
  • Review
  • Open Access
16 Citations
7,535 Views
35 Pages

Biomedical Application of MSCs in Corneal Regeneration and Repair

  • Maria P. De Miguel,
  • Marta Cadenas-Martin,
  • Martha Stokking and
  • Ana I. Martin-Gonzalez

The World Health Organization estimates that approximately 285 million people suffer from visual impairments, around 5% of which are caused by corneal pathologies. Currently, the most common clinical treatment consists of a corneal transplant (kerato...

(This article belongs to the Special Issue Biomedical Applications of Mesenchymal Stem Cells)

of 14